J D Ji

Summary

Country: Korea

Publications

  1. ncbi Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2
    J D Ji
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, 126 1, Anam Dong 5 Ga, Sungbuk Gu, Seoul 136 705, South Korea
    Rheumatology (Oxford) 44:983-8. 2005
  2. ncbi Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies
    Y H Lee
    College of Medicine, Korea University, Seongbuk Ku, Seoul
    Clin Rheumatol 20:420-2. 2001
  3. ncbi Associations between the p53 codon 72 polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seongbuk gu, Seoul, Korea
    Lupus 21:430-7. 2012
  4. ncbi The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, College of Medicine, Korea University, Anam Dong, Seongbuk Ku, Seoul, Korea
    Lupus 14:842-5. 2005
  5. ncbi Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
    Lupus 13:188-91. 2004
  6. ncbi Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
    Scand J Rheumatol 32:235-9. 2003
  7. ncbi Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, Korea University College of Medicine, Seoul, Korea
    Lupus 18:9-15. 2009
  8. ncbi Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus
    Y H Lee
    Department of Intemal Medicine, College of Medicine, Korea University, Seoul
    Lupus 10:601-5. 2001
  9. ncbi p53 codon 72 polymorphism and rheumatoid arthritis
    Y H Lee
    Department of Internal Medicine, College of Medicine, Korea University, Seoul
    J Rheumatol 28:2392-4. 2001
  10. ncbi The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
    Lupus 21:60-7. 2012

Collaborators

Detail Information

Publications21

  1. ncbi Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2
    J D Ji
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, 126 1, Anam Dong 5 Ga, Sungbuk Gu, Seoul 136 705, South Korea
    Rheumatology (Oxford) 44:983-8. 2005
    ..The anti-inflammatory effect of IL-10 is mediated via activated STAT3 (signal transducer and activator of transcription 3). In this study, we investigated whether 15d-PGJ2 inhibit IL-10-induced STAT activation...
  2. ncbi Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies
    Y H Lee
    College of Medicine, Korea University, Seongbuk Ku, Seoul
    Clin Rheumatol 20:420-2. 2001
    ..However, further studies are required to discover the possible contribution of the polymorphisms of the CTLA-4 and Fas to the pathogenesis of SpA...
  3. ncbi Associations between the p53 codon 72 polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seongbuk gu, Seoul, Korea
    Lupus 21:430-7. 2012
    ..The aim of this study was to determine whether the p53 codon 72 polymorphism confers susceptibility to systemic lupus erythematous (SLE) and rheumatoid arthritis (RA)...
  4. ncbi The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, College of Medicine, Korea University, Anam Dong, Seongbuk Ku, Seoul, Korea
    Lupus 14:842-5. 2005
    ..Further studies for replications are needed to confirm that the p53 polymorphism contributes to SLE...
  5. ncbi Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
    Lupus 13:188-91. 2004
    ..In conclusion, our data show that the eNOS ab genotypes may be associated with the development of lupus nephritis, suggesting individuals who carry the 'a' allele are more susceptible to lupus nephritis than those with the 'b' allele...
  6. ncbi Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
    Scand J Rheumatol 32:235-9. 2003
    ..Our data show that the functional promoter polymorphism in the MMP-1 promoter may not play an important role in the susceptibility of RA, but the polymorphism may be related to clinical phenotypes...
  7. ncbi Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, Korea University College of Medicine, Seoul, Korea
    Lupus 18:9-15. 2009
    ..031). In conclusion, this meta-analysis demonstrated an association of the PD1.3A allele with LN in European and SLE in Latin-American populations. Furthermore, the PD1.5C allele was associated with SLE susceptibility in Europeans...
  8. ncbi Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus
    Y H Lee
    Department of Intemal Medicine, College of Medicine, Korea University, Seoul
    Lupus 10:601-5. 2001
    ..05. Clinically, in the lupus patients there was no significant difference according to the CTLA-4 polymorphisms. In conclusion, no correlation was found between CTLA-4 exon 1 (+49) and promoter (-318) polymorphisms and SLE in our study...
  9. ncbi p53 codon 72 polymorphism and rheumatoid arthritis
    Y H Lee
    Department of Internal Medicine, College of Medicine, Korea University, Seoul
    J Rheumatol 28:2392-4. 2001
    ..To investigate whether the p53 codon 72 polymorphism is associated with susceptibility to rheumatoid arthritis (RA) and its clinical features...
  10. ncbi The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
    Lupus 21:60-7. 2012
    ..In conclusion, this meta-analysis demonstrates that the IL-6 -174 G/C polymorphism may confer susceptibility to SLE in Europeans, but that the IL-6 -572 G/C polymorphism is not associated with susceptibility to SLE in Asians...
  11. ncbi Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
    Lupus 18:727-34. 2009
    ..This meta-analysis shows that the FcgammaRIIB T/I232 polymorphism confers susceptibility to SLE, especially in Asian-derived populations...
  12. ncbi Genome scan meta-analysis of rheumatoid arthritis
    S J Choi
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, 126-1 Ka, Anam-dong, Seongbuk-Ku, Seoul 136-705, Korea
    Rheumatology (Oxford) 45:166-70. 2006
    ..These data may provide a basis to carry out targeted linkage and candidate gene studies, particularly in the regions...
  13. ncbi Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
    Y H Lee
    Department of Internal Medicine, Division of Rheumatology, Korea University Medical Centre, Korea University College of Medicine, Seoul, Korea
    Scand J Rheumatol 39:271-8. 2010
    ..The aim of this study was to assess the efficacy and safety of tacrolimus in patients with active rheumatoid arthritis (RA)...
  14. ncbi The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea
    Rheumatology (Oxford) 46:49-56. 2007
    ....
  15. ncbi Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
    Lupus 21:865-71. 2012
    ....
  16. ncbi Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis
    Y H Lee
    Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
    Lupus 19:703-10. 2010
    ..010), and was associated with a lower infection risk (RR 0.688, 95% CI 0.523-0.905, p-value 0.008). In conclusion, MMF was found to be as effective as CYC and tended to have a better safety profile as an induction therapy for LN than CYC...
  17. ncbi Exudative pleural effusion and pleural leukocytoclastic vasculitis in limited scleroderma
    Y H Lee
    Department of Internal Medicine, College of Medicine, Korea University, Seoul
    J Rheumatol 25:1006-8. 1998
    ..We describe a 43-year-old woman with limited scleroderma who developed an exudative pleural effusion associated with pleural leukocytoclastic vasculitis...
  18. ncbi A case of BOOP developed during bucillamine treatment for rheumatoid
    Y H Lee
    Division of Rheumatology, College of Medicine, Korea University, Seoul, Korea
    Korean J Intern Med 16:36-9. 2001
    ..Bucillamine was stopped and 50 mg of prednisolone was administered. His symptoms and infiltrations on the chest X-ray resolved. We suggest that bucillamine should be considered as a drug possibly associated with BOOP...
  19. ncbi Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus
    Y H Lee
    Department of Internal Medicine, College of Medicine, Korea University, Seoul
    J Rheumatol 28:2008-11. 2001
    ..To evaluate whether the polymorphism of Fas promoter -670 is associated with susceptibility to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) and their clinical features...
  20. ncbi Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes
    J D Ji
    Department of Biochemistry, Korea University College of Medicine, Sungbuk-gu, Seoul, Korea
    J Autoimmun 17:215-21. 2001
    ..Furthermore, PPAR-gamma activation induces apoptosis by itself and augments TRAIL/Apo2L-induced apoptosis in THP-1 cells. These results suggest that PPAR-gamma agonists may provide a new therapeutic approach for RA...
  21. ncbi Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Y W Park
    Division of Rheumatology, The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea
    Scand J Rheumatol 32:356-63. 2003
    ..ActD, CHX, and MG132 rendered cultured synovial fibroblasts susceptible to TRAIL-induced apoptosis by a caspase-dependent mechanism. However, the exact mechanism of sensitization by these metabolic inhibitors remains to be determined...